Axatilimab
Drug timelines are a Plus or Pro feature.
23 regulatory and trial events tracked for Axatilimab, covering 2022-07-22 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial [Phase 2]